Document Detail


Cytokine patterns after therapy with Avonex®, Rebif®, Betaferon® and CinnoVex™ in relapsing-remitting multiple sclerosis in Iranian patients.
MedLine Citation:
PMID:  20945990     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
AIM: Several lines of evidence exist which suggest that changes in the expression of circulating cytokines are linked to the development or reoccurrence of multiple sclerosis (MS). This study aimed to evaluate the serum levels of relevant cytokines after therapy with IFN-β formulations in MS patients.
MATERIALS & METHODS: In this study, blood samples were collected from 70 MS patients undergoing four different types of IFN-β formulation treatment and 100 healthy controls. After 24 months of treatment, the serum levels of IL-17A, IL-12, IFN-γ and IL-10 in patients and healthy controls were analyzed by ELISA.
RESULTS: Our results demonstrated that serum levels of IL-17A were significantly higher in patients treated with CinnoVex™ and Avonex® when compared with healthy controls. Serum levels of IL-10 were significantly decreased after therapy with CinnoVex, whereas serum levels of IFN-β were elevated. No difference in serum levels of IL-12 were detected between patients and controls.
CONCLUSION: Results of our study suggest that CinnoVex and Avonex modulate the immune system less than Rebif® and Betaferon® in MS patients, and an elevated dose of CinnoVex and Avonex may be required for better regulation of the immune system in MS patients.
Authors:
Mohammad Kazemi Arababadi; Reza Mosavi; Hossein Khorramdelazad; Narges Yaghini; Ebrahim Rezazadeh Zarandi; Majid Araste; Reza Pourali; Zohre Nekhei; Derek Kennedy
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Biomarkers in medicine     Volume:  4     ISSN:  1752-0371     ISO Abbreviation:  Biomark Med     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101312535     Medline TA:  Biomark Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  755-9     Citation Subset:  IM    
Affiliation:
Department of Microbiology, Hematology & Immunology, School of Medicine, Rafsanjan University of Medical Sciences, Iran. kazemim@modares.ac.ir
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vascular dysfunction biomarkers are elevated in children with HIV.
Next Document:  miRNAs as biomarkers for management of patients with colorectal cancer.